Topiramate Tablet, Film Coated
Product Images NDC 70518-4515

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 70518-4515). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 01)

Image (9df497de Be9f 4244 A769 A72a0e64dc42 01)
Chemical structure of topiramate, showing its molecular arrangement including multiple rings, oxygen atoms, and a sulfonamide group, consistent with the generic drug topiramate.*
FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 02)

Image (9df497de Be9f 4244 A769 A72a0e64dc42 02)
A Kaplan-Meier plot showing cumulative rates for time to first seizure over 500 days, comparing topiramate 50 mg/day versus 400 mg/day. The graph displays two cumulative incidence curves with data points for 234 and 236 subjects, respectively, and includes a statistical significance marker (p = 0.0002). The x-axis represents time in days, and the y-axis shows cumulative rates.*
FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 03)

Image (9df497de Be9f 4244 A769 A72a0e64dc42 03)
A bar chart comparing the change from baseline to double-blind phase in average monthly migraine period rate for placebo and three doses of topiramate (50 mg/day, 100 mg/day, and 200 mg/day) across two studies. The x-axis lists treatment groups with sample sizes; the y-axis shows change in migraine rate. Bars for topiramate doses show greater reduction than placebo, with statistical significance indicated.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Topiramate 25 mg film-coated tablets are shown in a label indicating a package quantity of 120 tablets. The label includes the NDC number 70518-4515-00 and specifies that the product is repackaged by RemedyRepack Inc., Indiana, PA. The tablets are described as round and yellow. Storage instructions and manufacturer information are included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.